Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01859715 · ClinicalTrials.gov registry record · NA
Emergency Department (ED) Drug Interaction in Emergency Department Patients
A NA study of Drug Interactions, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 502
- Enrollment target
- 1
- Study location
NCT01859715 is a NA study of Drug Interactions that has completed, run by University of Colorado, Denver. The registered enrollment target is 502 participants, below the 646-participant average among 6 other Drug Interactions trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01859715, a NA study of Drug Interactions, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 502 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines how hepatic cytochrome CYP2D6 drug interactions affects the efficacy of oxycodone, hydrocodone, and ondansetron in Emergency Department (ED) patients.
Conditions Studied
Interventions
- DRUG Oxycodone
- DRUG Ondansetron
- DRUG Hydrocodone
Study Locations (1)
Colorado
- University of Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 502 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01859715
The ClinicalTrials.gov registry entry for NCT01859715 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 502 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 646-participant average among 6 other Drug Interactions trials with a reported enrollment target (22% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Drug Interactions appearing as the primary indexed condition, and to 3 interventions - of which Oxycodone is the first listed.
NCT01859715 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT01859715 about?
NCT01859715 is a clinical study titled "Emergency Department (ED) Drug Interaction in Emergency Department Patients". This study examines how hepatic cytochrome CYP2D6 drug interactions affects the efficacy of oxycodone, hydrocodone, and ondansetron in Emergency Department (ED) patients.
What is the current status of trial NCT01859715?
This trial is currently completed. It is a NA study. The enrollment target is 502 participants. The study started on 2012-06. Estimated completion is 2013-02.
What conditions does trial NCT01859715 study?
This clinical trial studies the following conditions: Drug Interactions.
What interventions are being tested in trial NCT01859715?
The interventions under investigation include: Oxycodone (DRUG), Ondansetron (DRUG), Hydrocodone (DRUG).
Who is sponsoring clinical trial NCT01859715?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01859715 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Interactions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Shared Decision for Drug Interactions in Oral Anticoagulation
RECRUITING · NA
-
Opioid Drug Interaction Study
RECRUITING · Phase 1
-
LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering
RECRUITING · Phase 4
-
Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects
COMPLETED · Phase 1
-
Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)
COMPLETED · Phase 1
-
Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.